Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Reimann

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2025
High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of MoldovaDumitru Chesov, Maja Reimann, Tishya Mukherjee, et al.
Tuberculosis (Edinburgh, Scotland)|January 1, 2025
Blood levels of Mycobacterium tuberculosis (Mtb)antigen-triggered immune markers in people exposed to tuberculosis with regard to Mtb infection status and receipt of tuberculosis preventive therapyPetter Holmberg, Martina Janoušková, Tobias Schmidt, et al.
Emerging Infectious Diseases|April 20, 2023
Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, MoldovaEcaterina Noroc, Dumitru Chesov, Matthias Merker, et al.
Journal of Fungi (Basel, Switzerland)|August 26, 2021
Seroprevalence of <i>Aspergillus</i>-Specific IgG Antibody among Mozambican Tuberculosis PatientsHelmut J F Salzer, Isabel Massango, Nilesh Bhatt, et al.
The Journal of Infection|October 12, 2023
Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of MoldovaElena Chesov, Dumitru Chesov, Maja Reimann, et al.
Infection and Drug Resistance|July 1, 2026
Diagnostic Yield of Nontuberculous Mycobacteria Testing in Patients with Chronic Lung Diseases: A Retrospective Cohort StudyMateja Jankovic Makek, Ena Tolic, Christoph Lange, et al.
Clinical Microbiology Reviews|March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New StrategiesJan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
The Journal of Infection|December 29, 2024
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/RifMarit Neumann, Maja Reimann, Dumitru Chesov, et al.
The European Respiratory Journal|September 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden countryElena Chesov, Dumitru Chesov, Florian P Maurer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2023
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standardHelmut J F Salzer, Maja Reimann, Carolin Oertel, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2025
High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of MoldovaDumitru Chesov, Maja Reimann, Tishya Mukherjee, et al.
Tuberculosis (Edinburgh, Scotland)|January 1, 2025
Blood levels of Mycobacterium tuberculosis (Mtb)antigen-triggered immune markers in people exposed to tuberculosis with regard to Mtb infection status and receipt of tuberculosis preventive therapyPetter Holmberg, Martina Janoušková, Tobias Schmidt, et al.
Emerging Infectious Diseases|April 20, 2023
Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, MoldovaEcaterina Noroc, Dumitru Chesov, Matthias Merker, et al.
Journal of Fungi (Basel, Switzerland)|August 26, 2021
Seroprevalence of <i>Aspergillus</i>-Specific IgG Antibody among Mozambican Tuberculosis PatientsHelmut J F Salzer, Isabel Massango, Nilesh Bhatt, et al.
The Journal of Infection|October 12, 2023
Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of MoldovaElena Chesov, Dumitru Chesov, Maja Reimann, et al.
Infection and Drug Resistance|July 1, 2026
Diagnostic Yield of Nontuberculous Mycobacteria Testing in Patients with Chronic Lung Diseases: A Retrospective Cohort StudyMateja Jankovic Makek, Ena Tolic, Christoph Lange, et al.
Clinical Microbiology Reviews|March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New StrategiesJan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
The Journal of Infection|December 29, 2024
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/RifMarit Neumann, Maja Reimann, Dumitru Chesov, et al.
The European Respiratory Journal|September 10, 2021
Emergence of bedaquiline resistance in a high tuberculosis burden countryElena Chesov, Dumitru Chesov, Florian P Maurer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2023
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standardHelmut J F Salzer, Maja Reimann, Carolin Oertel, et al.
Pageof 4